Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia.
Yutaka Harano,Takeshi Miyawaki,Junko Nabiki,Miki Shibachi,Tomomi Adachi,Michiko Ikeda,Fukuhiro Ueda,Takamitsu Nakano +7 more
TLDR
The cookie test provided more informations compared with OGTT using liquid glucose and with fewer side effects, and improved insulin sensitivity over non-exercise group was obverved.Abstract:
A new cookie test was developed for the simultaneous evaluation of multiple risk factors such as glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. The cookie consisting of 75 g carbohydrate and 25 g fat is ingested and the blood samples are obtained at 0, 1 and 2 hours later. When the two carbohydrate sources, liquid glucose and test cookie, were compared as a glucose load within 3 months, the 2 hr plasma glucose levels were not statistically different, proposing the use of the same criteria at 2 hour glucose level for the diagnosis of diabetes and impaired glucose tolerance (IGT) in subjects without exocrine pancreatic dysfunction. In addition, hyperinsulinemia, insulin resistance (AUC insulin, and/or AUC insulin X AUC glucose), and postprandial hyperlipidemia (DeltaTG, Triglyceride; DeltaRLP, remnant like particles) have been simultaneously uncovered. Reactive hypoglycemia with adverse epigastric discomfort was observed in 26.3% of the control subjects with liquid glucose, while it was observed in only 1 case (5.3%) without any symptom with cookie tests. In fact, one reactive hypoglycemia out of 5 with liquid glucose turned out to be IGT with cookie test. In 64 subjects with lifestyle-related diseases, cookie test revealed hyperinsulinemia and insulin resistance in 56% respectively, postprandial hyperlipidemia in 39%, diabetes and IGT in 22-23% of each of the subjects and all showed at least one abnormal value. In contrast, in university students with exercise habit, all showed normal results with cookie test. In addition, improved insulin sensitivity over non-exercise group was obverved. In summary, the cookie test provided more informations compared with OGTT using liquid glucose and with fewer side effects. Simultaneous evaluation of glucose intolerance, hyperinsulinemia, insulin resistance, and postprandial hyperlipidemia was also possible.read more
Citations
More filters
Journal ArticleDOI
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart,Jean-Luc Davignon,Michel P. Hermans,Khalid Al-Rubeaan,Pierre Amarenco,Gerd Assmann,Philip J. Barter,John Betteridge,Eric Bruckert,Ada Cuevas,Michel Farnier,Ele Ferrannini,Paola Fioretto,Jacques Genest,Henry N. Ginsberg,Antonio M. Gotto,Dayi Hu,Takashi Kadowaki,Tatsuhiko Kodama,Michel Krempf,Yuji Matsuzawa,Jesús Millán Núñez-Cortés,Carlos Calvo Monfil,Hisao Ogawa,Jorge Plutzky,Daniel J. Rader,Shaukat Sadikot,Raul D. Santos,Evgeny Shlyakhto,Piyamitr Sritara,Rody G. Sy,Alan R. Tall,Chee Eng Tan,Lale Tokgozoglu,Peter P. Toth,Paul Valensi,Christoph Wanner,Alberto Zambon,Junren Zhu,Paul Zimmet +39 more
TL;DR: Monitoring of non-HDL cholesterol provides a simple, practical tool for treatment decisions regarding the management of lipid-related residual cardiovascular risk, and several emerging treatments may offer promise.
Journal ArticleDOI
Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
TL;DR: Compared to fenofibrate, K-877 has more potent PPARα-activating efficacy in vitro, greater effects on triglycerides- and HDL-C levels in humans, and a reduced risk of adverse effects.
Journal ArticleDOI
Postprandial hyperlipidemia as a potential residual risk factor
TL;DR: Postprandial hyperlipidemia is an important and residual risk factor especially in patients with insulin resistance syndrome (metabolic syndrome) and diabetes mellitus and further studies are needed to establish effective treatment.
Journal ArticleDOI
Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
Takahiro Sawada,Hideo Tsubata,Naoko Hashimoto,Michinori Takabe,Taishi Miyata,Kosuke Aoki,Soichiro Yamashita,Shogo Oishi,Tsuyoshi Osue,Kiminobu Yokoi,Yasue Tsukishiro,Tetsuari Onishi,Akira Shimane,Yasuyo Taniguchi,Yoshinori Yasaka,Takeshi Ohara,Hiroya Kawai,Mitsuhiro Yokoyama +17 more
TL;DR: EPA corrected postprandial hypertriglyceridemia, hyperglycemia and insulin secretion ability and was accompanied by recovery of concomitant endothelial dysfunction in newly diagnosed IGM patients with CAD.
Journal ArticleDOI
Identification of differential responses to an oral glucose tolerance test in healthy adults.
Ciara Morris,Colm M. O'Grada,Miriam F. Ryan,Helen M. Roche,Michael J. Gibney,Eileen R. Gibney,Lorraine Brennan +6 more
TL;DR: This work demonstrated that there were four distinct metabolic responses to the OGTT, with Cluster 1 having the highest BMI, triacylglycerol, hsCRP, c-peptide, insulin and HOMA- IR score and lowest VO2max.
References
More filters
Journal ArticleDOI
Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
TL;DR: The correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Journal ArticleDOI
Clinical significance, pathogenesis, and management of postprandial hyperglycemia.
TL;DR: This review summarizes epidemiologic and experimental studies linking postprandial hyperglycemia to cardiovascular disease and therapeutic approaches available and in development to treat this disorder.
Journal ArticleDOI
Disorders of Carbohydrate Metabolism
TL;DR: The laboratory diagnosis of neonatal disorders of carbohydrate metabolism, including hypoglycemia, hyperglycemia and disorders of fructose metabolism, glycogen storage diseases, and galactosemia, is outlined.
Journal ArticleDOI
Plasma Insulin and Glucose Responses of Healthy Subjects to Varying Glucose Loads During Three-hour Oral Glucose Tolerance Tests
TL;DR: The fact that incremental changes in glucose load particularly influenced plasma glucose and insulin concentrations relatively late in the glucose tolerance tests, and that mean insulin peakconcentrations did not differ, indicates that increasing glucose load results in a more prolonged insulinogenic stimulus rather than the acute release of greater quantities of insulin relatively abruptly.
Journal ArticleDOI
Restrictive smoking policies in the workplace: effects on smoking prevalence and cigarette consumption.
Robert W. Jeffery,Steven H. Kelder,Jean L. Forster,Simone A. French,Harry A. Lando,Judith Baxter +5 more
TL;DR: The present data are believed to support the idea that restrictive smoking policies have beneficial effects on the smoking habits of employees, but that the magnitude of this effect is modest.